how should we use a deauville score when employing pet imaging for our lymphoma patients?
Published 7 years ago • 13K plays • Length 22:09Download video MP4
Download video MP3
Similar videos
-
15:00
debate: hodgkin lymphoma patient who remains pet at the end of chemotherapy - radiation therapy
-
13:16
debate: hodgkin lymphoma patient who remains pet at the end of chemotherapy - sct-based therapy
-
22:57
how should we approach the adolescent/young adult hodgkin lymphoma patient?
-
15:57
initial therapy of advanced stage hodgkin lymphoma: when to use abvd, a(bv)vd, and beacopp
-
15:15
debate: best second-line approach to induce lymphoma remission prior to sct? - brentuximab
-
21:18
what to use and to improve the evaluation of responses - the role of pet/ct in functional imaging
-
18:55
how i manage advanced stage hodgkin lymphoma and what do i do at first relapse
-
21:23
going beyond positron emission tomography (pet): new imaging approaches
-
8:23
debate: should we do surveillance imaging for dlbcl patients in remission? - no
-
22:34
what’s new in the initial management of hodgkin lymphoma?
-
15:36
do any prognostic tools offer value in managing patients with hodgkin lymphoma?
-
17:53
key insights in lymphoma
-
15:04
debate: best second line therapy for relapsed hodgkin lymphoma - brentuximab alone/ chemo
-
22:26
expert perspectives: lymphoma
-
3:02
development of a patient decision aid on the benefits and harms of shoulder surgery
-
16:32
debate: best upfront approach for advanced stage hodgkin lymphoma? - a (brentuximab vedotin) vd
-
14:34
debate: best pre-transplant second line therapy for relapsed hodgkin lymphoma - chemo alone
-
2:17
what is the watch and wait approach?